Form 4: Adicet Bio Chief Scientific Officer Reports Tax-Related Stock Transaction
SEC Form 4 Filing
Blake Aftab, Chief Scientific Officer of Adicet Bio, reports a transaction involving the withholding of shares to cover tax obligations related to vesting restricted stock units.
Summary
- On January 24, 2025, Blake Aftab, the Chief Scientific Officer of Adicet Bio, Inc. (ACET), had 6,270 shares of common stock withheld by the issuer to satisfy tax withholding obligations.
- The price per share for the transaction was $0.9218.
- Following the transaction, Aftab directly owns 56,241 shares of Adicet Bio common stock.
Sentiment
Score: 5
Explanation: The document reports a routine transaction (tax withholding) and has no inherent positive or negative implications for the company's outlook.
Industry Context
Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it is a standard tax withholding procedure.
Key Dates
| Date | Description |
|---|---|
| 01/24/2025 | Date of the stock transaction (tax withholding). |
| 01/28/2025 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.